loading page

Impact of COVID-19 in early breast cancer management: a summary of the current evidence
  • +11
  • Francisco Pimentel Cavalcante,
  • Edson Abdala,
  • Leonardo Weissmann,
  • Carlos Eduardo dos Santos Ferreira,
  • Gilberto Amorim,
  • Gustavo Aguiar Campana,
  • Vilmar Marques de Oliveira,
  • Gisah Guilgen,
  • Luciana Landeiro,
  • João Renato Rebello Pinho,
  • Álvaro Pulchinelli Jr,
  • Heber Ribeiro,
  • Rafael Souza,
  • Daniela Dornelles Rosa
Francisco Pimentel Cavalcante
Brazilian Society of Mastology, Fortaleza General Hospital, Breast Surgery

Corresponding Author:[email protected]

Author Profile
Edson Abdala
USP, School of Medicine, Department of Infectious and Parasitic Diseases
Leonardo Weissmann
Brazilian Society of Infectology, Unaerp Medicina, Guarujá, Emílio Ribas Infectious Disease Institute
Carlos Eduardo dos Santos Ferreira
Brazilian Society of Clinical Pathology/Laboratory Medicine, Albert Einstein Hospital
Author Profile
Gilberto Amorim
GBECAM, Oncologia D’Or
Gustavo Aguiar Campana
Brazilian Society of Clinical Pathology/Laboratory Medicine, DASA
Vilmar Marques de Oliveira
Santa Casa de São Paulo School of Medical Sciences, Santa Casa de São Paulo Hospital, Brazilian Society of Mastology
Gisah Guilgen
GBECAM, Nossa Senhora das Graças Hospital, Curitiba Cancer and Transplant Institute
Luciana Landeiro
Núcleo de Oncologia da Bahia (NOB) - Oncoclínicas Group
João Renato Rebello Pinho
Albert Einstein Hospital , Hospital das Clínicas, School of Medicine, University of São Paulo, Medical Research
Álvaro Pulchinelli Jr
Fleury Group, Brazilian Society of Clinical Pathology/Laboratory Medicine, UNIFESP, School of Medicine (EPM)
Heber Ribeiro
AC Camargo Cancer Center, Brazilian Society of Oncology Surgery
Rafael Souza
Cancer Treatment Institute (ITC)
Daniela Dornelles Rosa
Federal University of Health Sciences of Porto Alegre (UFCSPA), GBECAM, Moinhos de Vento Hospital


Purpose: An Expert Panel on Breast Cancer and COVID-19 was convened to address the impact of the COVID-19 pandemic for early breast cancer management.
Methods: In order to ensure the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The Expert Panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform (Within3 ®).
Results: This paper reports the Expert Panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of breast cancer patients in clinical settings routinely encountered by HCPs amid the COVID-19 pandemic.
Conclusions: It was provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.